文献速递慢性肾脏病遗传性与小管间质肾病

多学科团队方法用于CKD相关骨质疏松症

Multidisciplinary team approach for CKD-associated osteoporosis.
PubMed 文献 · Nephrol Dial Transplant · 2024-01-01

本文介绍欧洲肾性骨营养不良(EUROD)倡议提出的肾脏-骨骼多学科团队(MDT)概念,用于CKD相关骨质疏松症的诊断与临床管理。EUROD于2021年启动虚拟临床-病理病例会议,选取4例代表性病例(涵盖CKD G5D骨折、移植后骨病、骨矿化障碍、骨转换严重抑制及重度甲旁亢),由肾内科、内分泌科和风湿科医生组成的MDT提供诊疗意见。MDT意见在多数情况下互补且对病例原有处理有增益,作者推荐在地方、国家和国际层面建立此类MDT。

要点

  • CKD-MBD显著增加CKD患者心血管疾病和骨折负担。
  • 骨活检虽非强制,但对复杂病例的诊断评估仍有用。
  • 肾脏-骨骼MDT可改善CKD相关骨质疏松症的诊断和个体化治疗。

核心结论

  • 肾脏-骨骼MDT对CKD-MBD患者管理具有临床实用性,推荐在地方、国家和国际层面建立。

研究设计与样本

  • EUROD倡议于2021年启动虚拟临床-病理病例会议,选取4例CKD相关骨质疏松症代表性病例,由肾内科、内分泌科和风湿科医生组成的MDT提供诊疗意见。

主要发现

  • 4例病例涵盖CKD G5D骨折、移植后骨病、骨矿化障碍、骨转换严重抑制和重度甲状旁腺功能亢进。
  • MDT意见在多数情况下相互补充,并对病例中原有处理方案有增益。

临床怎么用

  • 对CKD相关骨质疏松症的疑难病例,可借助肾脏-骨骼MDT综合肾内科、内分泌科和风湿科意见进行诊断和治疗决策。
  • 骨活检虽非强制,但在复杂病例的诊断评估中仍有用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic kidney disease-mineral and bone disorder (CKD-MBD) contributes substantially to the burden of cardiovascular disease and fractures in patients with CKD. An increasing arsenal of diagnostic tools, including bone turnover markers and bone imaging, is available to support clinicians in the management of CKD-associated osteoporosis. Although not mandatory, a bone biopsy remains useful in the diagnostic workup of complex cases. In this special report, the European Renal Osteodystrophy (EUROD) initiative introduces the concept of a kidney-bone multidisciplinary team (MDT) for the diagnosis and clinical management of challenging cases of CKD-associated osteoporosis. In 2021, the EUROD initiative launched virtual clinical-pathological case conferences to discuss challenging cases of patients with CKD-associated osteoporosis, in whom a bone biopsy was useful in the diagnostic workup. Out of these, we selected four representative cases and asked a kidney-bone MDT consisting of a nephrologist, an endocrinologist and a rheumatologist to provide comments on the diagnostic and therapeutic choices. These cases covered a broad spectrum of CKD-associated osteoporosis, including bone fracture in CKD G5D, post-transplant bone disease, disturbed bone mineralization, severely suppressed bone turnover and severe hyperparathyroidism. Comments from the MDT were, in most cases, complementary to each other and additive to the presented approach in the cases. The MDT approach may thus set the stage for improved diagnostics and tailored therapies in the field of CKD-associated osteoporosis. We demonstrate the clinical utility of a kidney-bone MDT for the management of patients with CKD-MBD and recommend their establishment at local, national, and international levels.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Hansen D, Jørgensen HS, Andersen TL, et al. Multidisciplinary team approach for CKD-associated osteoporosis. Nephrol Dial Transplant. 2024. PMID: 39315700. doi:10.1093/ndt/gfae197

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。